~~<i id='463364F844'><strike id='463364F844'><tt id='463364F844'><pre id='463364F844'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：entertainment 2025-08-17 07:59:07 - browse：78

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Stanford president's case begs question: Who takes blame?

Wikipedia

knowledge

hotspot

focus

leisure time

hotspot

JustinSullivan/GettyImagesTheassaultonthedevelopmentofnewlifesavingtherapiescontinuesapace.Recently,

WSS

Study identifies new proteins linked to dementia risk 25 years later

Texas Department of Public Safety speaks out on migrant abuse allegations

Biden report: The neurospychology of memory and aging

Senators start work on Medicare physician payment reform

Gilead might be held responsible for not developing a drug

Medicare Advantage proposed rates disappoint insurers

knowledge

fashion

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

Robert F. Kennedy is pitching centrism on health, even on abortion

Medicare proposal to cover medical devices draws a mixed reaction

Hospitals struggle to profit from CAR

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Indian pharmaceutical industry in denial over drug

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Industry veterans launch new biotech VC with $310M

Medicare details structure of new drug price negotiation program

Texas Department of Public Safety speaks out on migrant abuse allegations

knowledge

Winning ticket for $1 billion Powerball jackpot sold in California

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

KalVista pill reduced swelling 'attacks' caused by genetic disease

'Revelatory' study finds a smoking impact that remains after quitting

Key House Republican on health care plans exit from Congress

The dental labor crisis is a moment of opportunity

hotspot

focus

leisure time

hotspot